middle.news
Island Pharmaceuticals Advances Dengue Trial, Secures A$3.5M Funding Boost
7:03pm on Monday 2nd of June, 2025 AEST
•
Pharmaceuticals
Read Story
Island Pharmaceuticals Advances Dengue Trial, Secures A$3.5M Funding Boost
7:03pm on Monday 2nd of June, 2025 AEST
Key Points
Positive safety and anti-dengue activity observed in Phase 2a prophylactic trial
Phase 2b therapeutic arm of ISLA-101 trial commenced post quarter
A$3.5 million raised via two-tranche placement to biotech investors
Phillip Lynch appointed Executive Chairman, strengthening leadership
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
ISLAND PHARMACEUTICALS (ASX:ILA)
OPEN ARTICLE